LAMBDAVISION INCORPORATED — National Aeronautics and Space Administration SBIR Phase III: FY25 SBIR PHASE III - IN SPACE PRODUCTION OF PROTEIN- BASED ARTIFICIAL RETINAS
LAMBDAVISION INCORPORATED — SBIR Phase III award from National Aeronautics and Space Administration.
Phase III transition / production-path signal
- Phase III work is typically non-SBIR set-aside follow-on. Seeing LAMBDAVISION INCORPORATED at Phase III is a strong transition indicator in this domain.
- Competitors studying dual-use scale-up should treat Phase III firms as graduation benchmarks, not just Phase I/II volume leaders.
- At $3,275,000, this is a large obligation for typical SBIR Phase sizing — worth reviewing for scope breadth and teaming opportunity.
- Tagged technology areas: Space & Satellite, Human Performance & Medical, Materials & Manufacturing. Follow those hubs for open topics and peer winners in the same cluster.
Summary
LambdaVision received almost $2 million from NASA for a Phase III SBIR project to manufacture protein-based artificial retinas in space. The work focuses on developing this medical technology through in-space production methods.
- Amount
- $3,275,000
- Agency
- National Aeronautics and Space Administration · National Aeronautics and Space Administration
- Program / Phase
- SBIR · Phase III
- NAICS
- 541713 · RESEARCH AND DEVELOPMENT IN NANOTECHNOLOGY
- Place of performance
- CT
- Period
- 2025-06-24 → 2028-03-23
Technology domains
Space & Satellite Human Performance & Medical Materials & Manufacturing
Description
FY25 SBIR PHASE III - IN SPACE PRODUCTION OF PROTEIN- BASED ARTIFICIAL RETINAS